Evidence map›Paper›PMID 37383245›Full record

ArticleOpen forum infectious diseases2023

Age Differences in Comorbidities, Presenting Symptoms, and Outcomes of Influenza Illness Requiring Hospitalization: A Worldwide Perspective From the Global Influenza Hospital Surveillance Network.

Melissa K Andrew, Henrique Pott, Lisa Staadegaard, John Paget, Sandra S Chaves, Justin R Ortiz, John McCauley, Joseph Bresee, Marta C Nunes, Elsa Baumeister and 19 more

Open access · goldAbstract read
In one paragraph

Article in Open forum infectious diseases, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed, 1 pooled it
5.1field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 1 synthesis or guideline pooled it, 24 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Observational
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

29 authors at 20 institutions in 20 countries.

Melissa K AndrewDalhousie University and Canadian Center for Vaccinology, Halifax, Canada.ORCID https://orcid.org/0000-0001-7514-8972
Henrique PottDalhousie University and Canadian Center for Vaccinology, Halifax, Canada.
Lisa StaadegaardNetherlands Institute for Health Care Research (Nivel), Utrecht, Netherlands.ORCID https://orcid.org/0000-0002-6985-3541
John PagetNetherlands Institute for Health Care Research (Nivel), Utrecht, Netherlands.
Sandra S ChavesFoundation for Influenza Epidemiology, Fondation de France, Paris, France.
Justin R OrtizCenter for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, Maryland, USA.
John McCauleyWHO Collaborating Centre for Reference and Research on Influenza, Crick Institute, London, United Kingdom.
Joseph BreseeCentre for Vaccine Equity, Task Force for Global Health, Atlanta, Georgia, USA.
Marta C NunesSouth African Medical Research Council, Vaccines & Infectious Diseases Analytics (VIDA) Research Unit, and Department of Science and Technology/National Research Foundation, South African Research Chair Initiative in Vaccine Preventable Diseases, Faculty of Health Sciences University of the Witwatersrand, Johannesburg, South Africa.
Elsa BaumeisterNational Reference Laboratory for Viral Respiratory Diseases, Virology Department, INEI-ANLIS, Buenos Aires, Argentina.
Sonia Mara RaboniMolecular Biology/Microbiology Research Laboratory, Universidade Federal do Paraná, Curitiba, Brazil.
Heloisa I G GiamberardinoEpidemiology, Immunization and Infection Control Department-Hospital Pequeno Principe, Curitiba, Paraná, Brazil.
Shelly A McNeilDalhousie University and Canadian Center for Vaccinology, Halifax, Canada.
Doris GomezGrupo de Investigación UNIMOL, Facultad de Medicina, Universidad de Cartagena, Cartagena de Indias, Colombia.
Tao ZhangSchool of Public Health, Fudan University, Shanghai, China.
Philippe VanhemsHôpital Edouard Herriot, Lyon, France.
Parvaiz A KoulSher-i-Kashmir Institute, Srinagar, India.
Daouda CoulibalyInstitut National d'Hygiène Publique (INHP), Abidjan, Côte d'Ivoire.
Nancy A OtienoKenya Medical Research Institute (KEMRI), Nairobi, Kenya.
Ghassan DbaiboCenter for Infectious Diseases Research, American University of Beirut, Beirut, Lebanon.
Maria Lourdes Guerrero AlmeidaInstituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran, Mexico City, Mexico.
Victor Alberto Laguna-TorresClínica Internacional, Instituto de Medicina Tropical Universidad Nacional Mayor de San Marcos, Lima, Peru.
Anca Cristina DrăgănescuNational Institute for Infectious Diseases "Prof. Dr. Matei Bals", Bucharest, Romania.
Elena BurtsevaFSBI "N.F. Gamaleya NRCEM" Ministry of Health of the Russian Federation (Federal Research Budgetary Institute "National Research Center of Epidemiology and Microbiology named after honorary academician N.F. Gamaleya), Moscow, Russia.
Anna SomininaSmorodintsev Research Institute of Influenza, St. Petersburg, Russia.
Daria DanilenkoSmorodintsev Research Institute of Influenza, St. Petersburg, Russia.
Snežana MedićInstitute of Public Health of Vojvodina, Novi Sad, Serbia.
Javier Diez-DomingoFISABIO, Valencia, Spain.
Bruno LinaUniversité de Lyon, Lyon, France.
Dalhousie University · CANetherlands Institute for Health Services Research · NLResearch Institute of Influenza · RUAdministración Nacional de Laboratorios e Institutos de Salud · ARAmerican University of Beirut · LBFondation de France · FRFudan University · CNFundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana · ESHôpital Edouard Herriot · FRHospital Erasto Gaertner · BRInstitut National d’Hygiène Publique · CIInstituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán · MXKenya Medical Research Institute · KEMinistry of Health of the Russian Federation · RUNational Institute of Research and Development for Biological Sciences · RONational University of San Marcos · PESher-i-Kashmir Institute of Medical Sciences · INSouth African Medical Research Council · ZAThe Francis Crick Institute · GBThe Task Force for Global Health · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: The Global Influenza Hospital Surveillance Network (GIHSN) was established in 2012 to conduct coordinated worldwide influenza surveillance. In this study, we describe underlying comorbidities, symptoms, and outcomes in patients hospitalized with influenza. Methods: Between November 2018 and October 2019, GIHSN included 19 sites in 18 countries using a standardized surveillance protocol. Influenza infection was laboratory-confirmed with reverse-transcription polymerase chain reaction. A multivariate logistic regression model was utilized to analyze the extent to which various risk factors predict severe outcomes. Results: Of 16 022 enrolled patients, 21.9% had laboratory-confirmed influenza; 49.2% of influenza cases were A/H1N1pdm09. Fever and cough were the most common symptoms, although they decreased with age ( Conclusions: Both virus and host factors contributed to influenza burden. We identified age differences in comorbidities, presenting symptoms, and adverse clinical outcomes among those hospitalized with influenza and benefit from influenza vaccination in protecting against adverse clinical outcomes. The GIHSN provides an ongoing platform for global understanding of hospitalized influenza illness.

Indexed as

ageepidemiologyhospitalizationinfluenzamortality

Identifiers

PMID37383245
PMCPMC10296081
OpenAlexW4375845575

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.